8-K 1 v91874e8vk.htm FORM 8-K Bioject Medical Technologies
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       
Date of Report (Date of earliest event reported):   July 29, 2003
   

BIOJECT MEDICAL TECHNOLOGIES INC.

(Exact name of registrant as specified in its charter)
     
Oregon   93-1099680
(State or other jurisdiction of incorporation
or organization)		   (I.R.S. Employer Identification No.)
     
211 Somerville Road, Route 202 North,    
Bedminster, NJ   07921
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (908) 470-2800

 

Item 7. Financial Statements and Exhibits
Item 12. Results of Operations and Financial Condition
SIGNATURES
EXHIBIT 99.1

Table of Contents

         
BIOJECT MEDICAL TECHNOLOGIES INC.
    FORM 8-K
    INDEX
                 
Item   Description   Page
 
 
Item 7.  
Financial Statements, Pro Forma Financial Information and Exhibits
     2  
Item 12.  
Results of Operations and Financial Condition
     2  
Signatures  
 
     3  

1

Table of Contents

Item 7. Financial Statements and Exhibits

(c) Exhibits

This list is intended to constitute the exhibit index:

  99.1   Press release dated July 29, 2003 regarding Bioject’s second quarter 2003 revenue and earnings.

Item 12. Results of Operations and Financial Condition

On July 29, 2003 Bioject announced a net loss of $2.4 million, or $(0.22) per share, on revenue of $1.4 million for its second quarter of 2003 ended June 30, 2003.

A copy of the July 29, 2003 press release is included as exhibit 99.1 hereto. This exhibit is not filed, but is furnished pursuant to Item 12. (a) of Form 8-K.

2

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

       
     
Date: July 29, 2003   BIOJECT MEDICAL TECHNOLOGIES INC.
    (Registrant)
     
     
    /s/ JAMES O’SHEA
   
    James O’Shea
Chairman of the Board, Chief Executive Officer
and President (Principal Executive Officer)
     
     
    /s/ JOHN GANDOLFO
   
    John Gandolfo
Chief Financial Officer and Vice President of Finance
(Principal Financial and Accounting Officer)

3